Emergence of Azole-Resistant Aspergillus fumigatus from Immunocompromised Hosts in India
Authors:
- 1 August 2018
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (8)
Abstract
This prospective study shows that the rate of azole-resistant Aspergillus fumigatus (ARAF) in an immunocompromised Indian patient population with invasive aspergillosis (IA) is low, 6/706 (0.8%). This low rate supports the continued use of voriconazole as the first line of treatment.Keywords
This publication has 61 references indexed in Scilit:
- Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2012
- Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms incyp51A, Upregulation ofcyp51A, and Integration and Activation of TransposonAtf1in thecyp51APromoterAntimicrobial Agents and Chemotherapy, 2011
- Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A GeneAntimicrobial Agents and Chemotherapy, 2011
- Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New DefinitionClinical Infectious Diseases, 2011
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and SpainAntimicrobial Agents and Chemotherapy, 2010
- Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology ModelingAntimicrobial Agents and Chemotherapy, 2010
- In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus SpeciesJournal of Clinical Microbiology, 2008
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2008
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A AlterationsAntimicrobial Agents and Chemotherapy, 2007